Understanding Peptides: A Comprehensive Guide to Their Safety and Efficacy
Updated: Sep 23
The Growing Interest in Peptides
“Doc, what do you think about peptides?”
I get asked this question almost every day. BPC-157, TB-500, CJC-1295, Ipamorelin, MOTS-c—new names seem to appear almost as quickly as new social media posts promoting them.
Someone hears about a peptide on a podcast. An influencer claims it transformed their recovery. A clinic promises better sleep, increased muscle mass, faster healing, or even a longer life.
Suddenly, an experimental compound starts to resemble established medicine. However, before we delve into individual peptides, we must clarify one crucial point:
How Do We Actually Know Whether a Treatment Works—and Whether It Is Safe?
I Am Not Anti-Peptide
On the contrary, we believe peptides have already transformed medicine.
Insulin is a peptide hormone. Modern incretin medications have revolutionized the treatment of obesity and diabetes. Additionally, other peptide-based drugs are utilized throughout endocrinology and various other medical fields.
Some experimental peptides currently under discussion may eventually become vital therapies. However, a significant distinction exists between a medication studied in thousands of humans and a compound that produced intriguing results in a mouse.
They may both be peptides, but they do not share the same level of evidence.
How Does an Idea Become Medicine?
Medical research typically progresses through several stages:
Laboratory Research → Animal Research → Human Trials → Regulatory Review → Ongoing Safety Monitoring
Each step addresses different questions.
Laboratory Research
Researchers may initially study a compound in cells or tissues. This can help demonstrate how something might work.
However, a cell in a laboratory dish is not a person. A molecule entering the human body may affect the immune system, metabolism, hormones, organs, and biological pathways that were never part of the original experiment.
So, when someone asserts:
“Studies show this works.”
My first question is:
What Kind of Studies?
Animal Research
Animal studies are valuable. They can help researchers understand biological effects, dosing, metabolism, and potential toxicity.
However, animals and humans are different. Something that dramatically improves healing in a mouse may not yield the same results in a human. Similarly, something that appears safe during a short animal experiment may pose risks when used by people for months or years.
When I encounter exciting animal research, my response is not:
“It doesn't work.”
Instead, I say:
“Great. Now let's study humans.”
That is how science should operate.
Then Come Human Trials
Even human research exists on different levels.
Phase 1
Early studies primarily examine safety, dosing, and how the body processes a drug.
Phase 2
Researchers begin to investigate whether it appears to work.
Phase 3
Larger studies provide much stronger information about benefits and risks. This distinction is crucial. A compound being “studied in humans” does not imply it has been proven effective. Twenty people using something for a few weeks cannot inform us about what may happen when thousands of people use it for years.
Study Size Matters
Study Duration Matters
What Researchers Actually Measured Matters
A Better Number Does Not Always Mean a Healthier Person
This is another area where hype can outpace science.
A peptide may alter a hormone level, inflammatory marker, growth factor, or body-composition measurement.
Interesting? Absolutely.
However, the more important questions are:
Did people actually feel better?
Did they heal faster?
Did they function better?
Did they avoid disease?
Did they live longer?
What risks accompanied the benefits?
A biological effect does not automatically translate into a meaningful health outcome.
The Most Dangerous Phrase: “There Is No Evidence It Is Dangerous”
We must exercise caution.
That statement can imply:
We studied this extensively and have not found a major safety problem.
Alternatively, it can mean:
Almost nobody has studied this properly, so we have no idea what the risks are.
These are entirely different situations.
UNKNOWN RISK ≠ LOW RISK
Not knowing that something is dangerous is not synonymous with knowing that it is safe.
And What Is Actually in the Vial?
This question is often overlooked.
Even when a particular molecule is scientifically interesting, the product being sold still matters.
Is it genuinely what the label claims?
Is the dose accurate?
Is it sterile?
Is it contaminated?
Has it been stored correctly?
A scientific study using a carefully manufactured product does not automatically validate every vial carrying the same peptide name.
The molecule matters, but so do purity, sterility, dose, and manufacturing quality.
Then Came Social Media
Social media has empowered patients to become more informed and engaged. However, it has also created a significant problem:
Social Media Moves Much Faster Than Science
A good clinical trial may take years to complete. In contrast, a viral video can gain traction in seconds. The algorithm does not inquire whether a treatment has been properly studied; it only asks whether you clicked.
This is why repetition can begin to resemble proof.
But:
Popularity Is Not a Phase of Clinical Research
Testimonials Are Not Clinical Trials
A Million Views Do Not Equal One Well-Designed Human Study
My Position
We are excited about the future of peptide medicine. Some of today's experimental compounds may become tomorrow's essential therapies. Others may fail. Some may reveal risks we do not yet understand.
That is normal. That is science.
What concerns us is when we bypass the process—when animal data becomes a treatment claim, a theoretical mechanism becomes a guarantee, and patients effectively become the experiment.
Innovation is vital, but we should never have to abandon scientific standards to pursue it.
Before Trying Any New Peptide, Ask Five Questions
Has it actually been studied in humans?
How many humans were involved?
What benefit was actually proven?
How long were people followed?
Where did the product actually come from?
These five questions can eliminate a remarkable amount of medical misinformation.
The Bottom Line
We believe peptide medicine has an exciting future. However, the future of medicine should be built on evidence—not algorithms.
We should remain open to innovation while being honest about what we know, what we do not know, and what may still carry unknown risks.
Sometimes the most responsible answer a physician can provide is:
“We Don't Know Yet.”
That may not go viral, but it may keep patients safe.
Next: Part 2—What Exactly Is a Peptide?
Next, we will explore what peptides actually are, how they function in the body, why some have become extraordinary medications, and what distinguishes established peptide medicine from the rapidly expanding world of experimental peptide therapy.
Evidence over hype. Science over social media. Patient safety first.
— Alex Foxman, MD, FACP, ABOM
Double Board-Certified in Internal Medicine & Obesity Medicine
Beverly Hills Institute
This article is for general educational purposes and does not constitute individualized medical advice.
Comments